Medical 21

About Medical 21

Medical 21 is a developmental stage medical device company focused on revolutionizing cardiac bypass surgeries. The company is developing an artificial graft designed to bypass lesions in the heart and other parts of the body, eliminating the need for additional incisions to harvest vessels from the patient's legs or arms. This innovation significantly decreases both procedure time for the surgical team and recovery time for the patient, while also reducing the risk of infection and preventing additional scarring, pain, and other complications. Medical 21 aims to improve the quality of life for patients and reduce costs for the healthcare system. The company operates in the medical device market and serves healthcare providers performing cardiac bypass surgeries. Its business model involves the commercialization and marketing of its artificial grafts, generating revenue through sales to hospitals and clinics. The team at Medical 21 possesses decades of experience in the development, manufacturing, sales, and marketing of medical products, both domestically and internationally.